Theodore R. Schroeder - 06 May 2021 Form 4 Insider Report for Nabriva Therapeutics plc

Role
Chief Executive Officer, Director
Signature
/s/ Robert Crotty, by power of attorney
Issuer symbol
N/A
Transactions as of
06 May 2021
Net transactions value
-$335
Form type
4
Filing time
10 May 2021, 17:53:15 UTC
Next filing
02 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NBRV Ordinary Shares Tax liability $335 -225 -0.13% $1.49 178,203 06 May 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These ordinary shares were withheld by the Issuer in order to satisfy tax withholding obligations upon the vesting of certain restricted share units.